Skip to main content
. 2018 Oct 15;123:268–276. doi: 10.1016/j.ejps.2018.07.048

Table 2.

Immunomodulatory properties of TLR7 agonists, conjugates and liposomes.

Sample EC50 nM MEC nM
Conjugates Unconjugated TLR7 Agonist (8) 483 ± 25 74
Unmodified TLR7 Agonist (9) 620 ± 19 190
DOPE-TLR7a + DMSO 9 ± 1 <1
DOPE-TLR7a − DMSO No activity (>2000 nM) No activity (>2000 nM)
Liposomes MLV 1% DOPE-TLR7a 45 ± 23 6
MLV 20% DOPE-TLR7a 34 ± 20 <2
MLV 20% DOPE-TLR7a + TDB 33 ± 19 <2
MLV + TDB 223 ± 173 <24
MLV no immunostimulatory agent >200,000 >200,000